NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 4, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	145	130	93	124	218	499
Market Cap Growth	-40.32%	40.40%	-25.00%	-43.31%	-56.21%	101.94%
Enterprise Value	119	114	72	61	111	348
Last Close Price	1.30	1.17	1.27	3.60	6.35	14.50
PS Ratio	13.09	11.78	8.23	8.87	35.05	111.90
PB Ratio	2.18	1.96	1.37	1.63	1.89	3.32
P/TBV Ratio	2.18	1.96	1.37	1.63	1.89	3.32
EV/Sales Ratio	12.08	10.27	6.39	4.34	17.86	78.06
Net Debt / Equity Ratio	-0.58	-0.58	-0.69	-0.66	-0.84	-0.93
Net Debt / EBITDA Ratio	1.16	1.16	1.11	1.23	2.81	5.71
Net Debt / FCF Ratio	0.90	0.90	1.24	1.04	2.37	5.29
Asset Turnover	0.14	0.14	0.13	0.13	0.04	0.05
Inventory Turnover	17.24	17.24	22.79	14.12	-	-
Quick Ratio	8.05	8.05	5.06	5.32	14.40	35.60
Current Ratio	10.02	10.02	6.15	6.67	15.40	37.02
Return on Equity (ROE)	-52.46%	-52.46%	-58.55%	-41.63%	-26.02%	-27.86%
Return on Assets (ROA)	-28.39%	-28.39%	-31.72%	-24.01%	-15.62%	-16.73%
Return on Capital Employed (ROCE)	-50.30%	-50.30%	-60.50%	-52.10%	-29.80%	-16.40%
Earnings Yield	-24.27%	-26.96%	-45.20%	-32.17%	-15.83%	-4.93%
FCF Yield	-29.73%	-33.03%	-40.79%	-38.72%	-18.74%	-5.28%
Buyback Yield / Dilution	-87.22%	-87.22%	-18.72%	-	-13.05%	-53.09%

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.